Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure

Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure

Maria Rosa Ballester,1,2 Eulàlia Roig,3,4 Ignasi Gich,1,2 Montse Puntes,1 Joaquín Delgadillo,2,5 Benjamín Santos,5 Rosa Maria Antonijoan1,21Drug Research Center (CIM), Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcel...

Full description

Bibliographic Details
Main Authors: Ballester MR, Roig E, Gich I, Puntes M, Delgadillo J, Santos B, Antonijoan RM
Format: Article
Language:English
Published: Dove Medical Press 2015-08-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/randomized-open-label-blinded-endpoint-crossover-single-dose-study-to--peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/randomized-open-label-blinded-endpoint-crossover-single-dose-study-to--peer-reviewed-article-DDDT

Similar Items